Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).

NCT06248177 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2024-11-19

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to evaluate the effect on the microbiota and the reduction in the number and/or intensity of symptoms of gastrointestinal discomfort of consuming a probiotic or placebo for 6 weeks in adult women and men.

The main questions to answer are:

1. To study changes in the alpha diversity of the microbiota.
2. To evaluate changes in the salivary cortisol.

For this purpose, a randomized, double blind crossover study has been designed.

Target sample size is 30 subjects.

Participants will be allocated in two groups for 16 weeks (6 weeks consuming one of the products + 4 weeks wash-out period + 6 weeks consuming the other product).

* Group 1 (n=15): 6 weeks daily consumption of one probiotic capsule + 4 weeks wash-out period+ 6 weeks daily consumption of one placebo capsule.
* Group 2 (n=15): 6 weeks daily consumption of one placebo capsule + 4 weeks wash-out period+ 6 weeks daily consumption of one probiotic capsule.

Conditions

  • Probiotic
  • Gastrointestinal Symptoms
  • Microbiota

Interventions

DIETARY_SUPPLEMENT

Probiotic

Probiotic capsules

DIETARY_SUPPLEMENT

Placebo

Placebo capsules

Sponsors & Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra

    lead OTHER

Principal Investigators

  • Fermín I Milagro Yoldi, PhD · University of Navarra

  • Idoia Ibero-Baraibar, PhD · University of Navarra

  • Carlos González-Navarro, PhD · University of Navarra

  • Santiago Navas-Carretero, PhD · University of Navarra

  • Gabriela Arias · University of Navarra

  • Roncesvalles Garayoa, PhD · University of Navarra

  • María Goñi · University of Navarra

  • Salomé Pérez · University of Navarra

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-16
Primary Completion
2024-06-30
Completion
2024-07-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06248177 on ClinicalTrials.gov